Osteoporosis Update

News
Slideshow

Bisphosphonates, teriparatide, vitamin D, calcium, raloxifene, vertebroplasty/kyphoplasty: here’s the latest on osteoporosis.

The use of oral bisphosphonates is in decline in the US, said Kenneth G. Saag, MD, MSc, Professor of Medicine at the University of Alabama at Birmingham, at the recent American College of Physicians Internal Medicine Meeting 2015 in Boston.Highlights of Dr Sagg’s presentation of strategies on osteoporosis management follow.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Delgocitinib Effective in Adolescents with CHE in Phase 3 DELTA TEEN Trial / image credit Sonja Molin, MD Queen’s University

Delgocitinib Effective in Adolescents with CHE in Phase 3 DELTA TEEN Trial

Grace Halsey
February 4th 2025
Article

With no FDA-approved treatments for moderate-to-severe chronic hand eczema in the teen population, the late-stage topline data are very promising.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

AI-Assisted Mammography Boosts Breast Cancer Detection by 29% in Large Study / Image credit: ©Gorodenkoff/AdobeStock

AI-Assisted Mammography Boosts Breast Cancer Detection by 29% in Large Study

Sydney Jennings
February 4th 2025
Article

Results from the MASAI clinical trial also showed that AI-assisted screening reduced screen-reading workload without increasing the rate of false-positives.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

FDA Approves Monthly Lecanemab for Early-Stage Alzheimer Disease: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Monthly Lecanemab for Early-Stage Alzheimer Disease: Daily Dose

Sydney Jennings
February 4th 2025
Article

Your daily dose of the clinical news you may have missed.

Symbravo Mechanism of Action and Patient Selection, with PI Stewart Tepper, MD / image credit Geisel School of Medicine, Dartmouth

Symbravo Mechanism of Action and Patient Selection, with PI Stewart Tepper, MD

Stewart Tepper, MD
February 4th 2025
Article

Tepper, principal investigator for phase 3 trials of Symbravo as acute treatment for migraine in adults, reviews the new drug's dual MOA and target patient populations.

© 2025 MJH Life Sciences

All rights reserved.